Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Contact
Credit Report
Financials
People
Ownership
Latest Activity
Mutual Companies
Documents
Repayment History
Viridian Therapeutics Europe Limited
Viridian Therapeutics Europe Limited is an active company incorporated on 25 February 2011 with the registered office located in London, City of London. Viridian Therapeutics Europe Limited was registered 14 years ago.
Watch Company
Status
Active
Active since
2 years 8 months ago
Company No
07543968
Private limited company
Age
14 years
Incorporated
25 February 2011
Size
Micro
Turnover is under
£1M
Balance sheet is under
£500,000
Under
10 employees
Confirmation
Submitted
Dated
25 February 2025
(6 months ago)
Next confirmation dated
25 February 2026
Due by
11 March 2026
(6 months remaining)
Last change occurred
2 years 6 months ago
Accounts
Submitted
For period
1 Mar
⟶
29 Feb 2024
(1 year)
Accounts type is
Micro Entity
Next accounts for period
28 February 2025
Due by
30 November 2025
(2 months remaining)
Learn more about Viridian Therapeutics Europe Limited
Contact
Address
Cannon Place, 78 Cannon Street
London
EC4N 6AF
England
Same address for the past
4 years
Companies in EC4N 6AF
Telephone
Unreported
Email
Unreported
Website
Unreported
See All Contacts
People
Officers
3
Shareholders
1
Controllers (PSC)
1
Seth Harmon
Director • American • Lives in United States • Born in Jun 1979
Jennifer Dianne Tousignant
Director • Attorney • American • Lives in United States • Born in Dec 1971
Mr Thomas Beetham
Director • Business Executive / Attorney • American • Lives in United States • Born in Sep 1969
Viridian Therapeutics, INC
PSC
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
No mutual companies found
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
29 Feb 2024
For period
1 Mar
⟶
29 Feb 2024
Traded for
12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£20
Same as previous period
Total Liabilities
£0
Same as previous period
Net Assets
£20
Same as previous period
Debt Ratio (%)
0%
Same as previous period
See 10 Year Full Financials
Latest Activity
Confirmation Submitted
5 Months Ago on 28 Mar 2025
Micro Accounts Submitted
9 Months Ago on 26 Nov 2024
Seth Harmon Appointed
9 Months Ago on 26 Nov 2024
Jennifer Dianne Tousignant Appointed
9 Months Ago on 26 Nov 2024
Viridian Therapeutics Inc (PSC) Details Changed
1 Year Ago on 8 Aug 2024
Olswang Cosec Limited Resigned
1 Year 5 Months Ago on 1 Apr 2024
Confirmation Submitted
1 Year 6 Months Ago on 26 Feb 2024
Miragen Therapeutics Inc (PSC) Details Changed
4 Years Ago on 21 Jan 2021
Viridian Therapeutics Inc (PSC) Details Changed
4 Years Ago on 20 Jan 2021
Miragen Therapeutics Inc (PSC) Appointed
9 Years Ago on 6 Apr 2016
Get Alerts
Get Credit Report
Discover Viridian Therapeutics Europe Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Second filing for the appointment of Seth Harmon as a director
Submitted on 3 Apr 2025
Confirmation statement made on 25 February 2025 with no updates
Submitted on 28 Mar 2025
Change of details for Viridian Therapeutics Inc as a person with significant control on 20 January 2021
Submitted on 26 Mar 2025
Notification of Miragen Therapeutics Inc as a person with significant control on 6 April 2016
Submitted on 21 Mar 2025
Change of details for Miragen Therapeutics Inc as a person with significant control on 21 January 2021
Submitted on 21 Mar 2025
Change of details for Viridian Therapeutics Inc as a person with significant control on 8 August 2024
Submitted on 21 Mar 2025
Withdrawal of a person with significant control statement on 20 March 2025
Submitted on 20 Mar 2025
Micro company accounts made up to 29 February 2024
Submitted on 26 Nov 2024
Appointment of Seth Harmon as a director on 26 November 2024
Submitted on 26 Nov 2024
Appointment of Jennifer Dianne Tousignant as a director on 26 November 2024
Submitted on 26 Nov 2024
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs